Revenue (TTM) Chart

View Revenue (TTM) for ALC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 10.63B
December 31, 2025 10.40B
September 30, 2025 10.19B
June 30, 2025 10.02B
March 31, 2025 9.925B
December 31, 2024 9.911B
September 30, 2024 9.761B
June 30, 2024 9.636B
March 31, 2024 9.562B
December 31, 2023 9.455B
September 30, 2023 9.274B
June 30, 2023 9.085B
March 31, 2023 8.880B
December 31, 2022 8.717B
Date Value
September 30, 2022 8.695B
June 30, 2022 8.657B
March 31, 2022 8.550B
December 31, 2021 8.291B
September 30, 2021 8.082B
June 30, 2021 7.818B
March 31, 2021 6.922B
December 31, 2020 6.833B
September 30, 2020 6.806B
June 30, 2020 6.836B
March 31, 2020 7.525B
December 31, 2019 7.508B
September 30, 2019 7.386B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 3.101B
Alphatec Holdings, Inc. 787.08M
Haemonetics Corp. 1.334B
LeMaitre Vascular, Inc. 256.28M
Penumbra, Inc. 1.454B